Saralasin and Sarile Are AT2 Receptor Agonists
2014 (English)In: ACS Medicinal Chemistry Letters, ISSN 1948-5875, Vol. 5, no 10, 1129-1132 p.Article in journal (Refereed) Published
Saralasin and sarile, extensively studied over the past 40 years as angiotensin II (Ang II) receptor blockers, induce neurite outgrowth in a NG108-15 cell assay to a similar extent as the endogenous Ang II. In their undifferentiated state, these cells express mainly the AT2 receptor. The neurite outgrowth was inhibited by preincubation with the AT2 receptor selective antagonist PD 123,319, which suggests that the observed outgrowth was mediated by the AT2 receptor. Neither saralasin nor sarile reduced the neurite outgrowth induced by Ang II proving that the two octapeptides do not act as antagonists at the AT2 receptor and may be considered as AT2 receptor agonists.
Place, publisher, year, edition, pages
2014. Vol. 5, no 10, 1129-1132 p.
Pharmaceutical Sciences Medicinal Chemistry
IdentifiersURN: urn:nbn:se:uu:diva-235670DOI: 10.1021/ml500278gISI: 000343016700012PubMedID: 25313325OAI: oai:DiVA.org:uu-235670DiVA: diva2:761592